FDA Approves Aloxi for Chemotherapy-Induced Nausea and Vomiting (CINV)

Aloxi (palonosetron) is a 5-HT3 receptor antagonist indicated for the prevention of delayed CINV caused by moderately emetogenic cancer chemotherapy.

Posted: July 2003

Related Articles:

View comments

Hide
(web3)